✦ LIBER ✦

11C-labelling of the benzodiazepine antagonist RO 15–1788, in two different positions, and its main metabolite RO 15–3890

✍ Scribed by C. Halldin; S. Stone-Elander; J-O. Thorell; A. Persson; G. Sedvall

Publisher: John Wiley and Sons
Year: 1989
Tongue: French
Weight: 112 KB
Volume: 26
Category: Article
ISSN: 0022-2135
DOI: 10.1002/jlcr.25802601161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

11C-labelling of Ro 15-1788 in two diffe

11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors

✍ Christer Halldin; Sharon Stone-Elander; Jan-Olov Thorell; Anders Persson; Göran 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 270 KB

Metabolism of the benzodiazepine antagon

Metabolism of the benzodiazepine antagonist 11C-Ro 15-1788 after intravenous administration in man

✍ Carl-Gunnar Swahn; Anders Persson; Stefan Pauli 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

The metabolic fate of the benzodiazepine antagonist RO 15-1788 labelled with "C was studied in plasma from human subjects after intravenous administration in connection with positron emission tomography. R o 15-1788 and its metabolites were separated by thin-layer chromatography and the radioactivit

A comparison of methods for the separati

A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans

✍ L. Barre; D. Debruyne; P. Abadie; M. Moulin; J.C. Baron 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 446 KB

The determination of the percentage of unchanged [11C]Ro 15-1788 with respect to total radioactivity, essential for the pharmacokinetic exploitation of data of blood radioactivity decrease obtained in PET studies, may be carried out with equal results using either an extraction procedure or a TLC me